755039-92-0 Usage
Uses
Used in Pharmaceutical Synthesis:
(R)-1-ethylpyrrolidin-3-ylamine is used as an intermediate in the synthesis of various pharmaceuticals. Its role in creating complex drug molecules is crucial, as it can be a key component in the development of new medications.
Used in Agrochemical Production:
In the agrochemical industry, (R)-1-ethylpyrrolidin-3-ylamine serves as an intermediate for the production of various agrochemicals, contributing to the development of pesticides and other agricultural products.
Used in Organic Chemistry:
As a building block in organic chemistry, (R)-1-ethylpyrrolidin-3-ylamine is utilized for the synthesis of a wide range of organic compounds, showcasing its versatility in chemical reactions.
Used in Medical Applications:
(R)-1-ethylpyrrolidin-3-ylamine has potential medical applications, particularly as a key building block in the synthesis of drugs for the treatment of diseases such as Alzheimer's, schizophrenia, and Parkinson's. Its role in developing therapeutic agents for these conditions is significant.
Used in Neuroprotection and Neurotrophic Research:
(R)-1-ethylpyrrolidin-3-ylamine has been studied for its potential neuroprotective and neurotrophic effects, which could lead to advancements in the treatment of neurological disorders and promote brain health.
Check Digit Verification of cas no
The CAS Registry Mumber 755039-92-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,5,5,0,3 and 9 respectively; the second part has 2 digits, 9 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 755039-92:
(8*7)+(7*5)+(6*5)+(5*0)+(4*3)+(3*9)+(2*9)+(1*2)=180
180 % 10 = 0
So 755039-92-0 is a valid CAS Registry Number.
755039-92-0Relevant academic research and scientific papers
METHODS OF TREATING LIVER DISEASES
-
Paragraph 00463, (2014/05/24)
The invention provides tricyclic compounds and their use in treating liver disorders, such as non-alcoholic steatohepatitis and related disorders (e.g., fibrosis). The compounds are contemplated to have activity against methionyl aminopeptidase 2.
PARTIALLY SATURATED TRICYCLIC COMPOUNDS AND METHODS OF MAKING AND USING SAME
-
Page/Page column 204, (2012/12/13)
The invention provides tricyclic compounds and their use in treating medical disorders, such as obesity. Pharmaceutical compositions and methods of making various tricyclic compounds are provided. The compounds are contemplated to have activity against methionyl aminopeptidase 2.
TROPANE COMPOUNDS
-
Page/Page column 378, (2009/05/30)
A compound according to Formula I or II: (I) or (II) wherein R1, R1b, R2, L1, and L2 and L2b are as defined in the specification, pharmaceutical compositions thereof, and methods of use thereof.
